diltiazem has been researched along with Pituitary Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geras-Raaka, E; Gershengorn, MC; Thaw, CN | 1 |
Borges, JL; Davis, M; Drake, C; Iranmanesh, A; Kaiser, DL; Lizzaralde, G; Nassberg, B; Rogol, AD; Santen, RJ; Thorner, MO | 1 |
1 trial(s) available for diltiazem and Pituitary Neoplasms
Article | Year |
---|---|
Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas.
Topics: Adenoma; Adult; Aged; Calcium; Diltiazem; Humans; Male; Middle Aged; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Pituitary Hormones, Anterior; Pituitary Neoplasms; Random Allocation; Thyrotropin | 1987 |
1 other study(ies) available for diltiazem and Pituitary Neoplasms
Article | Year |
---|---|
Benzodiazepines modulate voltage-sensitive calcium channels in GH3 pituitary cells at sites distinct from thyrotropin-releasing hormone receptors.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Calcium; Cell Line; Chlordiazepoxide; Diazepam; Diltiazem; Ion Channels; Kinetics; Nifedipine; Pituitary Neoplasms; Potassium; Receptors, Neurotransmitter; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 1988 |